Diagnostic relevance of overexpressed NOK mRNA in breast cancer

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4969-4973

  Moriai, Ryosuke ^a   Kobayashi, Daisuke ^a   Amachika, Tomoko ^a   Tsuji, Naoki ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; c erbB2; Diagnosis; mRNA expression; NOK

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE NOK; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 33845916568     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Blume-Jensen P and Hunter T: Oncogenic kinase signaling. Nature 411: 355-365, 2001.
2. Hubbard SR, Mohammadi M and Schlessinger J: Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem 273: 11987-11990, 1998.
3. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000.
4. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R et al: Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 10: 1049-1056, 1992.
5. Duffy MJ: Predictive markers in breast and other cancers: a review. Clin Chem 51: 494-503, 2005.
6. Press MF, Sauter G, Bernstein L, Villalobos IE, Mirlacher M, Zhou JY, Wardeh R, Li YT, Guzman R, Ma Y, Sullivan-Halley J, Santiago A, Park JM, Riva A and Slamon DJ: Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11: 6598-6607, 2005.
7. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ and Press M: Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20: 719-726, 2002.
8. Liu L, Yu XZ, Li TS, Song LX, Chen PL, Suo TL, Li YH, Wang SD, Chen Y, Ren YM, Zhang SP, Chang ZJ and Fu XY: A novel protein tyrosine kinase NOK that shares homology with platelet-derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 64: 3491-3499, 2004.
9. Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M and Sato N: Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res 65: 11018-11025, 2005.
10. Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A and Watanabe N: Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer. Anticancer Res 22: 2965-2969, 2002.
11. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R and Vidaud M: Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156, 1999.
12. Tsutsui S, Kataoka A, Ohno S, Murakami S, Kinoshita J and Hachitanda Y: Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res 8: 3454-3460, 2002.
13. Coltrera MD, Wang J, Porter PL and Gown AM: Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res 55: 2703-2708, 1995.
14. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D and deLapeyriere O: Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61: 170-176, 1995.
15. Ezzat S, Zheng L, Zhu XF, Wu GE and Asa SL: Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109: 69-78, 2002.
16. Wallenius V, Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, Kindblom LG and Jansson JO: Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol 156: 821-829, 2002.
17. Chen Y, Li YH, Chen XP, Gong LM, Zhang SP, Chang ZJ, Zhang XF, Fu XY and Liu L: Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice. Cancer Res 65: 10838-10846, 2005.